Novalik-Pharm launches a new drug based on meloxicam

We are pleased to announce that the pharmaceutical company Novalik-Pharm together with SANVEZZA LAB GmbH (Austria), is launching a meloxicam-based drug – Algesicam® in the form of an injection solution.

ALGEZIKAM® is a non-steroidal anti-inflammatory drug (NSAID) for quick, long-term and safe relief of exacerbations in inflammatory diseases of the musculoskeletal system, combining high quality with a reasonable price.

Anti-inflammatory, analgesic and antipyretic effects are manifested.